Division of Cardiothoracic Surgery, Spectrum Health, Grand Rapids, Michigan; Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Ann Thorac Surg. 2018 Jul;106(1):58-62. doi: 10.1016/j.athoracsur.2018.01.073. Epub 2018 Mar 1.
Minimally invasive aortic valve replacement (mAVR) is gaining clinical acceptance; however, it is associated with increased operative times because of the limited surgical field and access. The Cor-Knot (CK; LSI Solutions, Victor, NY) is an automated fastening device designed to facilitate suture fastening, but clinical data in mAVR are lacking.
From May 2014 to February 2017, 92 patients underwent mAVR at Spectrum Health in Grand Rapids, Michigan; 39 valves were secured with manually tied sutures, and 53 valves were entirely secured with the CK device. Preoperative characteristics and 30-day outcomes data were extracted from the local The Society of Thoracic Surgeons database and the patients' electronic medical records. Survival data were obtained from the Michigan State Social Security Death Index.
No significant differences in preoperative characteristics were noted between the two groups. Aortic cross-clamp time (72 ± 12 minutes vs 82 ± 15 minutes; p = 0.001) was significantly shorter with CK. There was no difference in the rate of postoperative mortality (0% vs 0%), stroke (0% vs 1.9%), atrial fibrillation (28% vs 33%), renal failure (0% vs 3.8%), or pacemaker implantation (5.1% vs 5.7%) between patients with manually tied sutures and patients with sutures fastened with the CK. Valve function on postoperative echocardiography and 1-year patient survival rates were similar.
In mAVR, the CK device was associated with reduced aortic cross-clamp time while providing equivalent clinical outcomes. Larger studies are needed to confirm the efficacy, safety, and cost-effectiveness of the CK device in minimally invasive aortic valve surgery.
微创主动脉瓣置换术(mAVR)越来越被临床接受,但由于手术视野和通道有限,手术时间延长。Cor-Knot(CK;LSI Solutions,Victor,NY)是一种自动化紧固装置,旨在方便缝线紧固,但在 mAVR 中缺乏临床数据。
2014 年 5 月至 2017 年 2 月,密歇根州大急流城的 Spectrum Health 进行了 92 例 mAVR;39 个瓣膜采用手动打结缝线固定,53 个瓣膜完全采用 CK 装置固定。从当地胸外科医师协会数据库和患者电子病历中提取术前特征和 30 天结局数据。生存数据从密歇根州社会安全死亡指数中获得。
两组患者术前特征无显著差异。CK 组主动脉阻断时间明显缩短(72±12 分钟 vs 82±15 分钟;p=0.001)。术后死亡率(0% vs 0%)、卒(0% vs 1.9%)、心房颤动(28% vs 33%)、肾衰竭(0% vs 3.8%)或起搏器植入(5.1% vs 5.7%)差异无统计学意义。术后超声心动图显示瓣膜功能和 1 年患者生存率相似。
在 mAVR 中,CK 装置可缩短主动脉阻断时间,同时提供等效的临床结局。需要更大的研究来证实 CK 装置在微创主动脉瓣手术中的疗效、安全性和成本效益。